Autism spectrum

Blakely Page Celebrates Winning the HeartShare Humanitarian Award

Retrieved on: 
Monday, April 8, 2024

Wayne, Pennsylvania, April 08, 2024 (GLOBE NEWSWIRE) -- Blakely Page , a significant leader in Pennsylvania’s finance industry, is thrilled to announce that he has won the HeartShare Humanitarian Award, which recognizes his significant contributions to the welfare of others.

Key Points: 
  • Wayne, Pennsylvania, April 08, 2024 (GLOBE NEWSWIRE) -- Blakely Page , a significant leader in Pennsylvania’s finance industry, is thrilled to announce that he has won the HeartShare Humanitarian Award, which recognizes his significant contributions to the welfare of others.
  • A PAM Rising Star, an annual listing by thewealthnet that recognizes the qualities and achievements of the individual within their sector, Blakely Page ’s achievement of winning the HeartShare Humanitarian Award at the Spring Gala and Auction in front of 1500 people further highlights his impressive dedication to helping support and placing a spotlight on vital charitable organizations.
  • Throughout his professional career Blakely Page has forged success in capital management and the financial industry.
  • A focus on philanthropic ventures has remained with Blakely Page throughout his career, as well as furthering the importance of education.

Bierman Autism Centers Unveils 'Adventures of Pilot the Penguin,' Educational Coloring Book, in Honor of Autism Acceptance Month

Retrieved on: 
Tuesday, April 2, 2024

This initiative highlights BAC's dedication to fostering understanding, igniting young imaginations, and actively engaging with families and communities about autism.

Key Points: 
  • This initiative highlights BAC's dedication to fostering understanding, igniting young imaginations, and actively engaging with families and communities about autism.
  • In celebration of Occupational Therapy Month, "Adventures of Pilot the Penguin" serves as a valuable resource for Occupational Therapists (OTs) at Bierman.
  • Our goal with this coloring book is to spark joy, foster educational discussions, and illuminate the incredible potential within children with autism."
  • “Adventures of Pilot the Penguin” represents more than just a coloring book; it embodies BAC's unwavering belief in the boundless potential of every child with autism.

Civil Rights Leader Areva Martin Intensifies Call for Justice in the Controversial Shooting of Autistic Teen, Challenges “Attempted Murder of a Peace Officer” Narrative

Retrieved on: 
Friday, March 29, 2024

The Sheriff’s Department's characterization of the incident as “Attempted Murder of a Peace Officer” in its media advisory demands examination.

Key Points: 
  • The Sheriff’s Department's characterization of the incident as “Attempted Murder of a Peace Officer” in its media advisory demands examination.
  • Instead, the department reflexively names their own deputy as a victim of Ryan's alleged criminal behavior.
  • "We reiterate our call for the full and immediate release of all body-camera footage and other evidence pertinent to the incident.
  • We recognize the intersectionality of individuals with disabilities and that their fight for disability rights is inextricably tied to the fight for racial justice and the civil rights of all people.

Dorney Park & Wildwater Kingdom to Host Iron Menace Ride for a Cause Event to Benefit Eagles Autism Foundation

Retrieved on: 
Thursday, March 28, 2024

Dorney Park is hosting an Iron Menace Ride for a Cause event benefiting the Eagles Autism Foundation on Friday, April 19, from 5pm – 9pm at Dorney Park.

Key Points: 
  • Dorney Park is hosting an Iron Menace Ride for a Cause event benefiting the Eagles Autism Foundation on Friday, April 19, from 5pm – 9pm at Dorney Park.
  • Dorney Park has chosen the Eagles Autism Foundation to be the charitable beneficiary for this event.
  • “Dorney Park is proud to share the spotlight created by excitement and enthusiasm for our new roller coaster Iron Menace with the Eagles Autism Foundation,” said Dorney Park Vice President and General Manager Jessica Naderman.
  • Dorney Park and the Eagles Autism Foundation are partnering with illustrator and Allentown artist Ryan Lynn.

Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

Retrieved on: 
Wednesday, March 27, 2024

Preclinical testing has shown that the administration of ALA-002 results in significantly lowered incidence of hyperthermia, the major adverse event elicited by racemic generic MDMA.

Key Points: 
  • Preclinical testing has shown that the administration of ALA-002 results in significantly lowered incidence of hyperthermia, the major adverse event elicited by racemic generic MDMA.
  • PharmAla’s patent application included in-vivo experimental animal data, which is generally held to be stronger evidence than computational, or in-silico, modeling.
  • The Company intends to pursue its own clinical research with the novel composition, either alone or with an out-licensing partner.
  • “We are incredibly pleased that USPTO has issued an allowance for the granting of the Composition of Matter patent for ALA-002.

Hopebridge Gears Up for World Autism Month, Spreads Awareness of 1 in 36 Autism Prevalence

Retrieved on: 
Monday, March 25, 2024

Hopebridge Autism Therapy Centers, one of the largest autism therapy providers in the nation, is preparing for an exciting month ahead: World Autism Month.

Key Points: 
  • Hopebridge Autism Therapy Centers, one of the largest autism therapy providers in the nation, is preparing for an exciting month ahead: World Autism Month.
  • Hopebridge emphasizes to the public that this is a time to recognize and raise awareness about autism spectrum disorder (ASD) acceptance and inclusion.
  • To Hopebridge, the month of April is an opportunity to ignite change for children, families and the autism community as a whole.
  • "World Autism Month is a time to celebrate the diversity and resilience of individuals on the autism spectrum,” said Hopebridge founder, Kim Strunk.

Rose Hill Partners with University of Guelph for Groundbreaking Study to Advance Research for the Potential Benefits of Psilocybin Mushrooms to Address Autism in the Adolescent Brain

Retrieved on: 
Thursday, March 21, 2024

This collaboration marks a significant milestone for both entities as they embark on a pioneering exploration of the potential benefits of psilocybin to address autism in the adolescent brain, the first-of-its-kind partnership in this space.

Key Points: 
  • This collaboration marks a significant milestone for both entities as they embark on a pioneering exploration of the potential benefits of psilocybin to address autism in the adolescent brain, the first-of-its-kind partnership in this space.
  • The collaborative preclinical research will focus on exploring and standardizing the chemical diversity of Rose Hill’s psilocybin mushrooms, legally imported from Jamaica to Canada for the work.
  • Additionally, utilizing a rodent model, the study will investigate their potential application in Autism Spectrum Disorders (ASD).
  • Psilocybin mushrooms, known for their psychoactive properties, have long captivated the scientific community's interest due to their potential therapeutic applications and unique biochemical composition.

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

Retrieved on: 
Thursday, March 14, 2024

TEL AVIV, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, today announced that it has successfully dosed the first patient in its SCI-210 clinical trial at the Soroka Medical Center for pediatric patients who have Autism Spectrum Disorder ("ASD"). This significant milestone follows the Company's recent announcement about the successful delivery of its innovative SCI-210 treatment to the clinical trial site, enabling the commencement of dosing.

Key Points: 
  • This significant milestone follows the Company's recent announcement about the successful delivery of its innovative SCI-210 treatment to the clinical trial site, enabling the commencement of dosing.
  • "Dosing the first patient is always an exciting moment in any clinical trial.
  • We are grateful to the patients, Professor Meiri and his team involved in the clinical trial.
  • Designed as a randomized, double-blind, placebo-controlled clinical trial with cross-over, the study will span 20 weeks and enroll 60 children.

Special Needs Network Secures Over $1 Million in Grant Funding for Groundbreaking Mental Health Initiative

Retrieved on: 
Tuesday, March 12, 2024

This program aims to address the disparities in autism identification and services, particularly among African American and LatinX students.

Key Points: 
  • This program aims to address the disparities in autism identification and services, particularly among African American and LatinX students.
  • Furthermore, SNN has received a $750,000 grant from the California Department of Health Services (DHCS) as part of the California Youth Behavioral Health (CYBH) initiative, dedicated to supporting mental health initiatives for youth.
  • This funding will bolster SNN's efforts to deliver culturally competent, anti-racist behavioral health services right in the communities that need them ymost.
  • Special Needs Network, Inc. is a nonprofit grassroots 501(c)(3) organization responding to the crisis of autism and other developmental disabilities in underserved communities.

As Autism in New Jersey Reaches 3rd Highest Rates in Nation, Inspira Health Fills Critical Gap in Providing Diagnoses and Resources for Families

Retrieved on: 
Monday, April 1, 2024

Inspira Health is proud to announce the opening of its new Autism Diagnostic Center (ADC) to address a critical need in Southern New Jersey.

Key Points: 
  • Inspira Health is proud to announce the opening of its new Autism Diagnostic Center (ADC) to address a critical need in Southern New Jersey.
  • The ADC is designed to offer early testing, diagnosis, and comprehensive resources to children and adults with Autism Spectrum Disorder (ASD).
  • However, other than the newly established diagnostic center, few options and availability exist in South Jersey.
  • Inspira Health’s ADC represents a pivotal step towards nurturing the wellbeing of children with ASD and their families.